Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin PK in Obese Patients
NCT03102658Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of micafungin in invasive fungal infection (IFI) (3 arms), sponsored by Radboud University Medical Center. Primary endpoint: Area Under the Plasma Concentration versus Time Curve (AUC0-48) at 48 hours. Started Jan 2017; status: completed.
02
Drugs
micafungin
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT03102658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03102658.